Tech Company Financing Transactions
BioVascular Funding Round
BioVascular, based in San Diego, scored $10.9 million from BB Biotech Ventures , Domain Associates and Merck Capital Ventures.
Transaction Overview
Company Name
Announced On
2/7/2008
Transaction Type
Venture Equity
Amount
$10,870,000
Round
Series C
Investors
BB Biotech Ventures (Lead Investor) (Martin Munchbach)
Domain Associates (Brian Dovey)
Merck Capital Ventures (Arno Hartmann)
Proceeds Purpose
The Series C funds will support the clinical development of BioVascular's therapeutics targeting platelet-mediated diseases, saratin and BVI-007.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12230 El Camino Real 100
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
BioVascular develops and commercializes drugs and devices for the control of for platelet mediated cardiovascular diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Parrish
Chief Medical Officer
Alison Pilgrim
VP - Bus. Development
Paul Glidden
VP - Operations
Christopher Bussineau
Browse more venture capital transactions:
Prev: 2/7/2008: OraMetrix venture capital transaction
Next: 2/7/2008: Kotura venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs